D-1444-2016 Class II Terminated
FDA drug recall D-1444-2016 was initiated by GlaxoSmithKline, LLC on Jul 18, 2016 and is designated Class II. Reason for recall: Penicillin Cross Contamination The recall status is terminated (terminated Aug 9, 2017). Affected quantity: 153,119 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 27, 2016
- Initiation Date
- Jul 18, 2016
- Termination Date
- Aug 9, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 153,119 tubes
Product description
Bactroban Nasal, (Mupirocin Calcium Ointment 2%), 1 gram Single Use Tubes, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0029-1526-11.
Reason for recall
Penicillin Cross Contamination
Distribution pattern
Nationwide and PR.
Code information
Lot #: C686801, C689267, C692405, Exp. Jul 2016; C698116, Exp. Sep 2016; C750793, C750794, C752166, C752805 and C754828, Exp. Nov 2017.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1444-2016
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026